How to obtain the EMA’s Single Marketing Authorization?

All human medicines derived from biotechnology and other high-tech methods must be evaluated by the European Medicines Agency (EMA) via the centralized procedure called single marketing authorization before they can be marketed and made available to patients in the EU. The evaluation process is carried out by the EMA’s Committee for Medicinal Products for Human Use (CHMP) with […]